Summary
For Year 2026-27, Neochem Bio Solutions reports the following shareholding: Total Promoters at 66.72%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0.18%, Domestic Institutional Investors at 15.82%, and Retail at 17.28%. This breakdown provides a quick snapshot of ownership distribution for Neochem Bio Solutions in 2026-27.
Neochem Bio Solutions FAQs
As of 04-2026, the promoter shareholding in Neochem Bio Solutions stands at 66.72% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Neochem Bio Solutions is 0.18% and 15.82% respectively.
The retail shareholding of the Neochem Bio Solutions is 17.28%.
Changes in shareholding patterns of Neochem Bio Solutions can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Neochem Bio Solutions are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Neochem Bio Solutions Associated Pages
